Evidence map›Paper›PMID 22245043›Full record

ArticleNeurotoxicology2012

Developmental origins of adult diseases and neurotoxicity: epidemiological and experimental studies.

Donald A Fox, Philippe Grandjean, Didima de Groot, Merle G Paule

Open access · greenAbstract read
In one paragraph

Article in Neurotoxicology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Managing mercury exposure in northern Canadian communities.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2016
    Review
  9. Preventive effects of imperatorin on perfluorohexanesulfonate-induced neuronal apoptosis via inhibition of intracellular calcium-mediated ERK pathway.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2016
    Article
  10. Article
  11. Environmental Chemical Assessment in Clinical Practice: Unveiling the Elephant in the Room.International journal of environmental research and public health · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Donald A FoxUniversity of Houston, College of Optometry, Houston, TX, USA. dafox@uh.edu
Philippe Grandjean
Didima de Groot
Merle G Paule
National Center for Toxicological Research · USUniversity of Houston · USUniversity of Southern Denmark · DK

Funding

Research Programming ModuleP30EY007551 · NEI · UNIVERSITY OF HOUSTON · PI VALLABH E DAS · 1988 to 2026
$16.4M
Mercury-Associated Neurobehavioral Deficit in ChildrenR01ES009797 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI GRANDJEAN, PHILIPPE ADAM · 2007 to 2011
$2.0M
Low-Level Prenatal Lead Exposure and Retinal ToxicityR01ES012482 · NIEHS · UNIVERSITY OF HOUSTON · PI FOX, DONALD A · 2003 to 2009
$1.7M
NEI NIH HHS EY07551NEI NIH HHS P30 EY007551NIEHS NIH HHS R01 ES009797NIEHS NIH HHS R01 ES012482NIEHS NIH HHS R01ES012482NIEHS NIH HHS R01 ES09797
6 · The paper itself

Abstract

To date, only a small number of commercial chemicals have been tested and documented as developmental neurotoxicants. Moreover, an increasing number of epidemiological, clinical and experimental studies suggest an association between toxicant or drug exposure during the perinatal period and the development of metabolic-related diseases and neurotoxicity later in life. The four speakers at this symposium presented their research results on different neurotoxic chemicals relating to the developmental origins of health and adult disease (DOHaD). Philippe Grandjean presented epidemiological data on children exposed to inorganic mercury and methylmercury, and discussed the behavioral outcome measures as they relate to age and stage of brain development. Donald A. Fox presented data that low-dose human equivalent gestational lead exposure produces late-onset obesity only in male mice that is associated with neurodegeneration. Didima de Groot presented results on prenatal exposure of rats to methylazoxymethanol and discussed the results in light of the etiology of western Pacific amyotrophic lateral sclerosis and Parkinson-dementia complex. Merle G. Paule addressed the long-term changes in learning, motivation and short-term memory in aged Rhesus monkeys following acute 24 h exposure to ketamine during early development. Overall, these presentations addressed fundamental issues in the emerging areas of lifetime neurotoxicity testing, differential vulnerable periods of exposure, nonmonotonic dose-response effects and neurotoxic risk assessment. The results indicate that developmental neurotoxicity results in permanent changes, thus emphasizing the need to prevent such toxicity.

Indexed as

AdolescentAdultAge FactorsAnimalsChildChild BehaviorChild DevelopmentDose-Response Relationship, DrugEnvironmental PollutantsFemaleHumansLeadLead Poisoning, Nervous System, AdultLead Poisoning, Nervous System, ChildhoodMaleMaternal ExposureEnvironmental PollutantsLeadmethylazoxymethanolMethylazoxymethanol AcetateMethylmercury Compounds

Identifiers

PMID22245043
PMCPMC3657611
OpenAlexW2007925359

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.